Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98,365,673
-
Total 13F shares
-
26,156,533
-
Share change
-
+23,604
-
Total reported value
-
$178,123,275
-
Price per share
-
$6.81
-
Number of holders
-
58
-
Value change
-
-$953,279
-
Number of buys
-
28
-
Number of sells
-
31
Institutional Holders of Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) as of Q4 2021
As of 31 Dec 2021,
Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,156,533 shares.
The largest 10 holders included
FMR LLC, Pentwater Capital Management LP, BlackRock Inc., NATIXIS, VANGUARD GROUP INC, Aisling Capital Management LP, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.